Fat Mass and Obesity‐Related (FTO) Gene Variant Is a Predictor of CVD in T2DM Patients
Journal of Diabetes Research · 2024
DOI: 10.1155/2024/5914316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2024. Verfasst von Mazhar Hussain und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department Sheikh Zayed Medical College, Rahim Yar Khan, Punjab, Pakistan. Hauptthemen laut MEDLINE: Alpha-Ketoglutarate-Dependent Dioxygenase FTO, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Obesity. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The role of the common FTO gene variant rs9939609 in obesity has been well established, and the FTO gene has a strong association with T2DM.
Objective
To investigate the association of FTO gene variant rs9939609 with obesity‐related parameters in T2DM and CVD patients. Materials and Methods: In this cross‐sectional study, 280 subjects of either sex aged 45.10 ± 9.6 years were randomly divided into four groups, that is, T2DM, T2DM with CVD, nondiabetic with CVD disease, and normal control. These samples were genotyped by ARMS‐PCR. The FTO gene association with obesity‐related parameters in T2DM and CVD patients was analyzed by SPSS 22.
Results
The TT genotype was the most common genotype (46.80%) in our study groups. The minor allele frequency (MAF) was significantly higher in T2DM patients (0.39 vs. 0.28), T2DM patients with CVD (0.43 vs. 0.28), and nondiabetic patients with CVD (0.35 vs. 0.28) as compared to control with p < 0.005. Carriers of the AA genotype of the FTO gene rs9939609 were significantly associated with increased BMI, WC, HbA1C, SBP, DBP, and TGs and lowered HDL cholesterol as compared to the TA and TT genotypes in T2DM and CVD patients with p < 0.005. The FTO gene variant rs9939609 showed a significant association with T2DM and CVD. The AA genotype odds ratio (OR) in T2DM was 1.48 (1.06–2.32), p = 0.006, and in CVD, it was 1.56 (1.04–2.4), p = 0.003.
Conclusion
The FTO gene variant rs9939609 has a strong association with T2DM and CVD. The AA genotype of FTO gene variants rs9939609 showed a strong association with most of the risk factors of CVD and T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology Department Sheikh Zayed Medical College, Rahim Yar Khan, Punjab, Pakistan.
- Pharmacology Department Riphah International University, Islamabad, Pakistan.
- Internal Medicine Residency Program South Texas Health GME Consortium Texas A & M School of Medicine, Bryan, Texas, USA.
- Community Medicine Department Sheikh Zayed Medical College, Rahim Yar Khan, Punjab, Pakistan.
ORCID-Profile: Mazhar Hussain, Asim Elahi, Ghulam Mustafa
Zitieren
APA
Hussain, M., Waheed, A., Elahi, A., & Mustafa, G. (2024). Fat Mass and Obesity‐Related (FTO) Gene Variant Is a Predictor of CVD in T2DM Patients. Journal of Diabetes Research. https://doi.org/10.1155/2024/5914316
Vancouver
Hussain M, Waheed A, Elahi A, Mustafa G. Fat Mass and Obesity‐Related (FTO) Gene Variant Is a Predictor of CVD in T2DM Patients. Journal of Diabetes Research. 2024. doi:10.1155/2024/5914316
BibTeX
@article{Hussain2024,
author = {Hussain, Mazhar and Waheed, Akbar and Elahi, Asim and Mustafa, Ghulam},
title = {Fat Mass and Obesity‐Related (FTO) Gene Variant Is a Predictor of CVD in T2DM Patients},
journal = {Journal of Diabetes Research},
year = {2024},
doi = {10.1155/2024/5914316}
}
EUVIMED